Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lianna Kadar"'
Publikováno v:
Annals of the New York Academy of Sciences. 904:584-591
Lung cancer is a major cause of death in many countries. To improve the results of treatment, more individualized therapy is necessary; for this, it is necessary to identify new prognostic factors. In 21 patients with lung cancer (17 with non-small-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::880e610f173fed1c9da7a8c8b7f44080
https://doi.org/10.1111/j.1749-6632.2000.tb06520.x
https://doi.org/10.1111/j.1749-6632.2000.tb06520.x
Autor:
Johan Areberg, Sören Mattsson, Fiona E. McNeill, Maria Albertsson, Mikael Linden, Lars Ahlgren, Lianna Kadar
Publikováno v:
Acta Oncologica. 38:431-437
A hospital-based facility for in vivo prompt gamma neutron activation analysis of nitrogen for body protein determination is described. The patient is laid on a movable couch and is scanned with a vertically collimated neutron beam from a 252Cf neutr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::504a11b4b4723e58bec74c74f74cef9f
https://doi.org/10.1080/028418699431951
https://doi.org/10.1080/028418699431951
Publikováno v:
Acta Oncologica. 45:103-105
10%) [1]. When the diagnosis is made,approximately 50% of patients are not candidates forcurative therapy due to locally advanced disease ormetastases. In this group of patients, median survivaltime is 6 months or less with or without palliativetreat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::004d38e3ab82e8ffcf166a3cf8270fa6
https://doi.org/10.1080/02841860500372319
https://doi.org/10.1080/02841860500372319
Autor:
Åke Berglund, Ingegerd Karlberg, Petra Flygare, Anders Johnsson, Michael Gubanski, Eva Fernebro, Bengt Glimelius, Lianna Kadar, Pehr Lind
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 13(3)
Background. The optimal chemotherapy in patients with advanced gastric carcinoma (GC) is yet to be determined. We compared sequential administration of docetaxel and irinotecan, both in combination with infused 5-fluorouracil/leucovorin (5-Fu/Lv), an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db3eea34da934779a93936027cec05ac
https://pubmed.ncbi.nlm.nih.gov/20820984
https://pubmed.ncbi.nlm.nih.gov/20820984
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 49(5-6)
Many cancer patients are affected by loss of appetite, weight loss and fatigue in the course of disease. These symptoms reduce the patients' quality of life, increase morbidity, and lessen tolerance to anti-tumor treatment. In some cases the symptoms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb068f9bdcd3afd8dd6c30fba77259e5
https://pubmed.ncbi.nlm.nih.gov/9569565
https://pubmed.ncbi.nlm.nih.gov/9569565
Autor:
Anne-Birgitte Jacobsen, H. Letocha, Lars Franzén, Nils Glenjen, Lianna Kadar, Signe Friesland, Charlotte Bratthall, Gun Wickart-Johansson, Ingunn Hatlevoll, Petra Weber Hauge, Gunnar Wagenius
Publikováno v:
Journal of Clinical Oncology. 30:e14531-e14531
e14531 Background: This is an open label, non-randomized, multicenter phase I-II study with Docetaxel (Doc) given in combination with capecitabine (Cap) in patients (pts) with metastatic oesophageal cancer (mEC) or cancer in the cardia region (mCCR).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d813e663d0b5f1848b7c473ad666fa8a
https://doi.org/10.1200/jco.2012.30.15_suppl.e14531
https://doi.org/10.1200/jco.2012.30.15_suppl.e14531
Autor:
Anders Johnsson, Lianna Kadar, I. Karlberg, Pehr Lind, Michael Gubanski, Eva Fernebro, Petra Flygare, Bengt Glimelius
Publikováno v:
Journal of Clinical Oncology. 26:4579-4579
4579 Background: The optimal chemotherapy combination in patients with metastatic gastric adenocarcinoma (GA) is yet to be determined. We compared two newer drugs, docetaxel (arm T) and irinotecan ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0ad70b8533c9da818ac87e951e9fea4
https://doi.org/10.1200/jco.2008.26.15_suppl.4579
https://doi.org/10.1200/jco.2008.26.15_suppl.4579